Larson, RA; Druker, BJ; Guillot, F; O'Brien, SG; Riviere, GJ; Krahnke, T; Gathmann, I; Wang, Y; Study Group, IRIS; Collaborator Solenthaler, M (2008). Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study. Blood, 111(8), pp. 4022-8. Washington, D.C.: American Society of Hematology 10.1182/blood-2007-10-116475
Full text not available from this repository.Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory |
UniBE Contributor: |
Solenthaler, Max |
ISSN: |
0006-4971 |
Publisher: |
American Society of Hematology |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 15:03 |
Last Modified: |
05 Dec 2022 14:19 |
Publisher DOI: |
10.1182/blood-2007-10-116475 |
Web of Science ID: |
000255134700023 |
Additional Information: |
- |
URI: |
https://boris.unibe.ch/id/eprint/27256 (FactScience: 105297) |
Actions (login required)
 |
Edit item |